Gynecomastia possibly induced by rosuvastatin

Pharmacotherapy

Volumn 28, Issue 4, 2008, Pages 549-551

  Oteri, Alessandro ^a   Catania, Maria Antonietta ^a   Travaglini, Rita ^b   Russo, Alessandra ^a   Giustini, Saffi E ^c   Caputi, Achille P ^a   Polimeni, Giovanni ^a,d  

^a UNIVERSITY OF MESSINA   (Italy)

^b Italian College of General Practitioners   (Italy)

^c Italian College of General Practitioners   (Italy)

^d IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

Author keywords

Endocrine adverse reaction; Gynecomastia; Rosuvastatin; Statins

Indexed keywords

ATORVASTATIN; ROSUVASTATIN;

ADULT; ARTICLE; CASE REPORT; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; GYNECOMASTIA; HUMAN; HYPERCHOLESTEROLEMIA; KIDNEY FUNCTION TEST; LIVER FUNCTION TEST; MALE; PHYSICAL EXAMINATION; THYROID FUNCTION TEST;

FLUOROBENZENES; GYNECOMASTIA; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PROBABILITY; PYRIMIDINES; PYRROLES; STEROIDS; SULFONAMIDES;

EID: 41549152976     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.28.4.549     Document Type: Article

References (23)

1. Carlson HE. Gynecomastia. N Engl J Med 1980;303:795-99.
2. Braunstein GD. Clinical practice. Gynecomastia. N Engl J Med 2007;357:1229-37.
3. Edmondson HA, Glass SJ, Soll SN. Gynecomastia associated with cirrhosis of the liver. Proc Soc Exp Biol Med 1939;42:97-9.
4. Gabrilove JL. Some recent advances in virilizing and feminizing syndromes and hirsutism. Mt Sinai J Med 1974;41:636-54.
5. Smals AG. Gynaecomastia. Neth J Med 1987;31:47-51.
6. Allee MR. Gynecomastia. Last updated November 16, 2006. eMedicine Journal [serial online]. Available from www.emedicine.com/med/topic934.htm.
7. Peyriere H, Mauboussin JM, Rouanet I, et al. Report of gynecomastia in five male patients during antiretroviral therapy for HIV infection. AIDS 1999;13:2167-9.
8. Thompson DF, Carter JR. Drug-induced gynecomastia. Pharmacotherapy 1993;13:37-45.
9. Hugues FC, Gourlot C, Le Jeunne C. Drug-induced gynecomastia. Ann Med Interne (Paris) 2000;151:10-17.
10. Aerts J, Karmochkine M, Raguin G. Gynecomastia due to pravastatin [case report]. Presse Med 1999;28:787.
11. Hammons KB, Edwards RF, Rice WY. Golf-inhibiting gynecomastia associated with atorvastatin therapy. Pharmacotherapy 2006;26:1165-8.
12. Anonymous. Simvastatin and adverse endocrine effects in men [case report]. Aust N Z J Public Health 1995;14:10.
13. Anonymous. Pharmaceutical preparations are usually the cause of gynecomastia [in Swedish]. Läkartidningen 1996;93:489-90.
14. Uppsala Monitoring Centre. Vigibase online: the World Health Organization's adverse drug reaction database. Available from http://www.who-umc.org. Accessed August 2, 2007.
15. Pfizer Ireland Pharmaceuticals. Lipitor (atorvastatin) package insert. Dublin, Ireland; 2004.
16. Novartis Pharmaceuticals Corporation. Lescol (fluvastatin) package insert. East Hanover, NJ; 2003.
17. Merck & Co., Inc. Mevacor (lovastatin) package insert. Whitehouse Station, NJ; 2005.
18. Rosenson RS. Rosuvastatin: a new inhibitor of HMG-CoA reductase for the treatment of dyslipidemia. Expert Rev Cardiovasc Ther 2003;1:495-50.
19. Astrazeneca SpA. Crestor (rosuvastatin) package insert. Basiglio, Italy; 2004.
20. Cornes PG, Hole AC. Amlodipine gynaecomastia. Breast 2001;10:544-5.
21. Komine N, Takeda Y, Nakamata T. Amlodipine-induced gynecomastia in two patients on long-term hemodialysis therapy. Clin Exp Nephrol 2003;7:85-6.
22. Zochling J, Large G, Fassett R. Gynaecomastia and amlodipine [case report]. Med J Aust 1994;160:807.
23. Naranjo CA, Busto U, Sellers EM, et al. A method of estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.